Views of Dutch general practitioners about premenstrual symptoms: A qualitative interview study

References

• Van der Leij F, Schultz WC, van de Wiel H, et al. [The premenstrual syndrome]. Ned Tijdschr Geneeskd. 2010;154:A1341. Dutch.
   PubMedGoogle Scholar
• The American College of Obstetricians and Gynecologists. Premenstrual syndrome (PMS). 2020. [cited 2020 December 17]. Available from: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/07/mental-health-disorders-in-adolescents
   Google Scholar
• Federation Medical Specialists. 2020. [cited 2020 December 4]. Available from: https://www.richtlijnendatabase.nl/richtlijn/premenstrueel_syndroom/premenstrueel_syndroom_-_startpagina.html. [in Dutch].
   Google Scholar
• Yonkers KA, O'Brien PMS, Eriksson E. Premenstrual syndrome. Lancet. 2008;371(9619):1200–1210.
   PubMed Web of Science ®Google Scholar
• Kolthof F, Labots-Vogelesang M, Lagro-Janssen T. [The premenstrual syndrome. Prevalence and characteristics in patients in a general practice]. Huisarts Wet. 2005;48:109–112. Dutch.
   Google Scholar
• Potter J, Bouyer J, Trussell J, et al. Premenstrual syndrome prevalence and fluctuation over time: results from a French population-based survey. J Womens Health (Larchmt). 2009;18(1):31–39.
   PubMed Web of Science ®Google Scholar
• Wittchen H-U, Becker E, Lieb R, et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002;32(1):119–132.
   PubMed Web of Science ®Google Scholar
• Direkvand-Moghadam AK, Sayehmiri K, Delpisheh A, et al. Epidemiology of premenstrual syndrome (PMS)-A systematic review and meta-analysis study. J Clin Diagn Res. 2014;8:106–109.
   PubMedGoogle Scholar
• Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiol Stress. 2020;12:100213.
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Martinez PE, Nieman LK, et al. Exposure to a change in ovarian steroid levels but not continuous stable levels triggers PMDD symptoms following ovarian suppression. AJP. 2017;174(10):980–989.
   Web of Science ®Google Scholar
• Liu Q, Wang Y, van Heck CH, et al. Stress reactivity and emotion in premenstrual syndrome. Neuropsychiatr Dis Treat. 2017;13:1597–1602.
   PubMed Web of Science ®Google Scholar
• Rapkin AJ, Winer SA. Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness. Expert Rev Pharmacoecon Outcomes Res. 2009;9(2):157–170.
   PubMedGoogle Scholar
• Ussher JM, Perz J. PMS as a gendered illness linked to the construction and relational experience of hetero-femininity. Sex Roles. 2013;68(1-2):132–150.
   Web of Science ®Google Scholar
• Eriksson O, Wall A, Olsson U, et al. Women with premenstrual dysphoria lack the seemingly normal premenstrual right-sided relative dominance of 5-HTP-derived serotonergic activity in the dorsolateral prefrontal cortices – A possible cause of disabling mood symptoms. PLoS One. 2016;11(9):e0159538.
   PubMed Web of Science ®Google Scholar
• Gillings MR. Were there evolutionary advantages to premenstrual syndrome? Evol Appl. 2014;7(8):897–904.
   PubMed Web of Science ®Google Scholar
• Nevatte T, O'Brien PM, Bäckström T, et al.; Consensus Group of the International Society for Premenstrual Disorders. ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health. 2013;16(4):279–291.
   PubMed Web of Science ®Google Scholar
• Ward K, Gott M, Hoare K. Participants' views of telephone interviews within a grounded theory study. J Adv Nurs. 2015;71(12):2775–2785.
   PubMed Web of Science ®Google Scholar
• ATLAS.ti: the qualitative data analysis & research software. Available from: https://atlasti.com
   Google Scholar
• Malterud K. Systematic text condensation: a strategy for qualitative analysis. Scand J Public Health. 2012;40(8):795–805.
   PubMed Web of Science ®Google Scholar
• Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357.
   PubMed Web of Science ®Google Scholar
• Ussher JM, Perz J. PMS as a process of negotiation: women's experience and management of premenstrual distress. Psychol Health. 2013;28(8):909–927.
   PubMed Web of Science ®Google Scholar
• Cohen LS, Miner CW, Brown EW, et al. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet Gynecol. 2002;100(3):435–444.
   PubMed Web of Science ®Google Scholar
• Eisenlohr-Moul TA, Rubinow DR, Schiller CE, et al. Histories of abuse predict stronger within-person covariation of ovarian steroids and mood symptoms in women with menstrually related mood disorder. Psychoneuroendocrinology. 2016;67:142–152.
   PubMed Web of Science ®Google Scholar
• Neill Epperson CN, Hantsoo LV. Making strides to simplify diagnosis of premenstrual dysphoric disorder. Am J Psychiatry. 2017;174(1):6–7.
   PubMed Web of Science ®Google Scholar
• Craner JR, Sigmon ST, Martinson AA, et al. Premenstrual disorders and rumination. J Clin Psychol. 2014;70(1):32–47.
   PubMed Web of Science ®Google Scholar
• Bosman RC, Albers CJ, de Jong J, et al. No menstrual cyclicity in mood and interpersonal behaviour in nine women with self-reported premenstrual syndrome. Psychopathology. 2018;51(4):290–294.
   PubMed Web of Science ®Google Scholar
• Lete I, Häusler G, Pintiaux A, et al. The inconvenience due to women's monthly bleeding (ISY) survey: a study of premenstrual symptoms among 5728 women in Europe. Eur J Contracept Reprod Health Care. 2017;22(5):354–359.
   PubMed Web of Science ®Google Scholar
• Leminen H, Heliovaara-Peippo S, Halmesmaki K, et al. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on premenstrual symptoms in women treated for menorrhagia: secondary analysis of a randomized controlled trial. Acta Obstet Gynecol Scand. 2012;91(3):318–325.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Cameron B, Gueorguieva R, et al. The Influence of cyclic hormonal contraception on expression of premenstrual syndrome. J Womens Health (Larchmt). 2017;26(4):321–328.
   PubMed Web of Science ®Google Scholar
• Ismaili E, Walsh S, O'Brien PMS, et al.; Consensus Group of the International Society for Premenstrual Disorders. Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder. Arch Womens Ment Health. 2016;19(6):953–958.
   PubMed Web of Science ®Google Scholar
• Lustyk MKB, Gerrish WG, Shaver S, et al. Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health. 2009;12(2):85–96.
   PubMed Web of Science ®Google Scholar
• Sepede G, Sarchione F, Matarazzo I, et al. Premenstrual dysphoric disorder without comorbid psychiatric conditions: a systematic review of therapeutic options. Clin Neuropharmacol. 2016;39(5):241–261.
   PubMed Web of Science ®Google Scholar
• Lovick T. SSRIs and the female brain-potential for utilizing steroid-stimulating properties to treat menstrual cycle-linked dysphorias. J Psychopharmacol. 2013;27(12):1180–1185.
   PubMed Web of Science ®Google Scholar